1. The Metabolism, Analysis, and Targeting of Steroid Hormones in Breast and Prostate Cancer

   • Cameron P. Capper
   • James M. Rae
   • Richard J. Auchus

   Review 11 March 2016 Pages: 149 - 164

   

2. TERT Promoter Mutations in Thyroid Cancer

   • Ali S. Alzahrani
   • Rawan Alsaadi
   • Bakr Bin Sadiq

   Review 22 February 2016 Pages: 165 - 177

   

3. Premenopausal Circulating Androgens and Risk of Endometrial Cancer: results of a Prospective Study

   • Tess V. Clendenen
   • Kathryn Hertzmark
   • Anne Zeleniuch-Jacquotte

   Original Paper 29 February 2016 Pages: 178 - 187

4. pAKT Expression and Response to Sorafenib in Differentiated Thyroid Cancer

   • Mark Yarchoan
   • Changqing Ma
   • Marcia S. Brose

   Original Paper 18 March 2016 Pages: 188 - 195

   

5. CUDC-101, a Novel Inhibitor of Full-Length Androgen Receptor (flAR) and Androgen Receptor Variant 7 (AR-V7) Activity: Mechanism of Action and In Vivo Efficacy

   • Huiying Sun
   • Sanjay N. Mediwala
   • Marco Marcelli

   Original Paper 08 March 2016 Pages: 196 - 210

   

6. Salvage Treatment of Adrenocortical Carcinoma with Trofosfamide

   • Matthias Kroiss
   • Timo Deutschbein
   • on behalf of the German Adrenocortical Carcinoma Study Group

   Original Paper 09 March 2016 Pages: 211 - 218